Form 4 for VCEL Vericel Corp
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-17 · accession 0001127602-23-006580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-22 | 2023-02-18+ | VCEL | Flynn Sean C. | SVP, GC | F - Tax | $29.82 | -1,987 | 5,258 | -27% | -$59.3K |
| DM | 2023-02-22 | 2023-02-18+ | VCEL | Flynn Sean C. | SVP, GC | M - OptEx | $0.00 | +4,075 | 6,413 | +174% | $0 |
| DM | 2023-02-22 | 2023-02-18+ | VCEL | Flynn Sean C. | SVP, GC | M - OptEx | — | -4,075 | 6,975 | -37% | — |
| DM | 2023-02-22 | 2023-02-17 | VCEL | Flynn Sean C. | SVP, GC | A - Grant | $0.00 | +42.0K | 28.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-19 | F | D | 832 | $29.82 | 6,176 | D | — | — | (F3) These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 2 | Common | Common Stock | 2023-02-19 | M | A | 1,750 | $0.00 | 7,008 | D | — | — | (F4) The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024, and February 19, 2025. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 3 | Common | Common Stock | 2023-02-18 | M | A | 2,325 | $0.00 | 6,413 | D | — | — | (F1) The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 4 | Common | Common Stock | 2023-02-18 | F | D | 1,155 | $29.82 | 5,258 | D | — | — | (F3) These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 5 | Derivative | Restricted Stock Unit | 2023-02-19 | M | D | 1,750 | — | 3,500 | D | — · — to — | 1,750 Common Stock | (F9) The Fair Market Value of the vested derivative securities is $29.82 per share. (F6) Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. (F4) The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024, and February 19, 2025. (F8) No expiration date for this type of award. |
| 6 | Derivative | Restricted Stock Unit | 2023-02-17 | A | A | 12,000 | $0.00 | 12,000 | D | — · — to — | 12,000 Common Stock | (F6) Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. (F7) These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 17, 2024. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. (F8) No expiration date for this type of award. |
| 7 | Derivative | Restricted Stock Unit | 2023-02-18 | M | D | 2,325 | — | 6,975 | D | — · — to — | 2,325 Common Stock | (F9) The Fair Market Value of the vested derivative securities is $29.82 per share. (F6) Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. (F1) The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively. (F8) No expiration date for this type of award. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-02-17 | A | A | 1,875 | $0.00 | 1,875 | D | $29.82 · — to 2033-02-17 | 1,875 Common Stock | (F5) These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-02-17 | A | A | 28,125 | $0.00 | 28,125 | D | $29.82 · — to 2033-02-17 | 28,125 Common Stock | (F5) These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. |